Recent Insider and Institutional Moves Reveal $NTRA’s Market Activity
On February 6, 2025, Solomon Moshkevich, the PRESIDENT of $NTRA, sold 1,632 shares of the company, bringing in an estimated $290,120. This sale represents about 1.1% of his shares in this stock class. Post-sale, Moshkevich now holds 149,768 shares of $NTRA.
Insider Trading Overview
In the last six months, insiders have traded $NTRA stock 171 times, all being sales with no purchases recorded.
Here’s a summary of notable insider sales:
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) reported 0 purchases and 13 sales, offloading 170,003 shares for around $28,179,841.
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) conducted 23 sales, selling 118,658 shares for about $18,601,599.
- ROELOF BOTHA executed 5 sales, totaling 87,473 shares sold for around $14,793,563.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) sold 85,958 shares across 24 transactions for an estimated $14,425,269.
- JONATHAN SHEENA reported 57 sales, selling 97,988 shares for an estimated $13,875,969.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICAL DIAGNOSTICS) engaged in 13 sales, selling 40,726 shares for about $6,658,479.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) made 9 sales, selling 34,908 shares for around $5,741,526.
- ROY D. BAYNES sold 37,230 shares across 6 transactions for an estimated $5,439,564.
- JOHN FESKO (PRESIDENT, CHIEF BUSINESS OFFICER) sold 32,016 shares through 12 transactions for an estimated $5,031,550.
- GAIL BOXER MARCUS sold 11,894 shares in 7 trades, totaling around $1,899,602.
- ROWAN E CHAPMAN sold 4,381 shares over 2 transactions for approximately $634,563.
For more details about insider transactions, please visit Quiver Quantitative’s insider trading dashboard.
Institutional Investor Activity in $NTRA
In the recent quarter, 246 institutional investors increased their $NTRA stock holdings, while 264 reduced their positions.
Notable moves include:
- PRICE T ROWE ASSOCIATES INC /MD/ boosted their holdings with an addition of 2,341,756 shares (+442.8%) for an estimated $297,285,924.
- WELLINGTON MANAGEMENT GROUP LLP expanded their portfolio with 1,883,481 shares (+205.4%) valued at approximately $239,107,912.
- DUQUESNE FAMILY OFFICE LLC increased their stake by 1,591,970 shares (+80.6%) worth around $202,100,591.
- JPMORGAN CHASE & CO trimmed its holdings by removing 1,433,790 shares (-23.6%), which accounts for an estimated $182,019,640.
- FRED ALGER MANAGEMENT, LLC decreased its position by 1,250,664 shares (-23.8%), valued at approximately $158,771,794.
- BLACKROCK, INC. added 947,457 shares (+11.5%) to their holdings in Q4 2024, estimated at $149,982,443.
- AMERIPRISE FINANCIAL INC reduced their holdings by 861,463 shares (-26.0%) for an estimated $109,362,727.
To explore more on hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.
Congressional Trading Activity in $NTRA
Members of Congress conducted a single trade involving $NTRA stock in the past six months, which consisted of one purchase and no sales.
For ongoing insights on congressional stock trading, visit Quiver Quantitative’s congressional trading dashboard.
This article is not financial advice. For more details, see Quiver Quantitative’s disclaimers.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
